Keywords

• Lifitegrast
• Top Purity 1025967-78-5

Quick Details

• ProName: Quality Factory Supply Top Purity 1025...
• CasNo: 1025967-78-5
• Molecular Formula: C29H24Cl2N2O7S
• Application: Healthcare providers prescribe lifiteg...
• ProductionCapacity: Metric Ton/Day
• Purity: 99%
• LimitNum: 0 Metric Ton

Superiority

Quality factory supply top purity 1025967-78-5 with efficient transportation, accept customization.

Details

Lifitegrast, marketed under the brand name Xiidra, is a medication designed for the treatment of the signs and symptoms associated with dry eye, a condition medically termed keratoconjunctivitis sicca. Dry eye syndrome occurs when there is an insufficient quantity or quality of tears to lubricate and nourish the eyes.

Quality Factory Supply Top Purity 1025967-78-5 Efficient Transportation

Lifitegrast functions as an immune-inhibiting medication and is administered in the form of eye drops. Its mechanism of action involves the reduction of inflammation by inhibiting the binding of inflammatory cells. Excessive inflammation can impede tear fluid production, contributing to the sensation of dry eyes. The recommended dosage is typically one drop of Xiidra instilled into each eye twice daily, with approximately 12 hours between doses. Single-use containers should be discarded immediately after use in each eye.

It is essential to follow the prescribed dosage and usage instructions provided by healthcare professionals. Additionally, individuals should not use Xiidra if they are allergic to any of its ingredients. Lifitegrast, through its antagonism of lymphocyte function-associated antigen-1 (LFA-1), works to reduce ocular surface inflammation. This immunomodulatory action makes it a suitable option for the management of the signs and symptoms associated with dry eye syndrome. Lifitegrast has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of keratoconjunctivitis sicca.